Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors

Abstract

Different molecular mechanisms are responsible for primary and secondary imatinib resistance in GISTs. These findings have implications for future approaches to the growing problem of imatinib resistance in patients with advanced GISTs.